Meridian Bioscience, Inc. (VIVO) Debt to Equity Ratio
Meridian Bioscience, Inc. (VIVO) debt-to-equity ratio history and balance sheet leverage. Analyze D/E ratio in Excel with MarketXLS.
Debt to Equity Ratio Data
| Period | Debt/Equity |
|---|---|
| 2018-03-31 | 0.60 |
| 2019-03-31 | 0.80 |
| 2019-06-30 | 0.96 |
| 2020-06-30 | 1.45 |
| 2021-06-30 | 0.57 |
| 2022-06-30 | 1.30 |
| 2023-06-30 | 8.65 |
| 2025-06-30 | 1.45 |
Debt to equity divides total borrowings by total shareholder equity at the period end. Total borrowings are short-term debt plus long-term debt, including capital lease obligations. Non-debt liabilities such as accounts payable and deferred revenue are excluded. A period is omitted when equity is negative, because the ratio is not meaningful then.
Get Meridian Bioscience, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Debt_to_Equity_Ratio("VIVO", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | VIVO | $4.35 | -0.23% | 0.36M |
| 3 | ||||
| 4 | ||||
| 5 |